Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Failure of Methylcellulose to alter the Growth of Walker Tumour 256 in Rats

Abstract

METHYLCELLULOSE is a long-chained methyl ether of cellulose. Recent reports have associated regression of the transplantable Murphy–Sturm lymphosarcoma in rats with treatment by intraperitoneal injections of methylcellulose1–4. In the present investigation the same type of rats and treatment were used with the Walker tumour 256. As will be shown, no beneficial effect was noted in the parameters studied, namely, size of the tumour and longevity of the rats.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Lazar, A., and Lazar, D., J. Nat. Cancer Inst., 28, 1255 (1962).

    CAS  PubMed  Google Scholar 

  2. Hruban, Z., Lazar, A., and Slesers, A., Lab. Invest., 12, 25 (1963).

    CAS  PubMed  Google Scholar 

  3. Lazar, A., Hruban, Z., Slesers, A., and Lazar, D., J. Amer. Med. Assoc., 183, 33 (1963).

    Article  Google Scholar 

  4. Lazar, A., and Lazar, D., Nature, 199, 48 (1963).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

LAZAR, A., ROTH, A. & LAZAR, D. Failure of Methylcellulose to alter the Growth of Walker Tumour 256 in Rats. Nature 209, 1140 (1966). https://doi.org/10.1038/2091140a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/2091140a0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing